Correlation Between NextCure and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both NextCure and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Unicycive Therapeutics, you can compare the effects of market volatilities on NextCure and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Unicycive Therapeutics.
Diversification Opportunities for NextCure and Unicycive Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NextCure and Unicycive is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of NextCure i.e., NextCure and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between NextCure and Unicycive Therapeutics
Given the investment horizon of 90 days NextCure is expected to generate 19.41 times less return on investment than Unicycive Therapeutics. But when comparing it to its historical volatility, NextCure is 2.27 times less risky than Unicycive Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 24.00 from holding Unicycive Therapeutics or generate 53.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.79% |
| Values | Daily Returns |
NextCure vs. Unicycive Therapeutics
Performance |
| Timeline |
| NextCure |
| Unicycive Therapeutics |
NextCure and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NextCure and Unicycive Therapeutics
The main advantage of trading using opposite NextCure and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |